84 related articles for article (PubMed ID: 439002)
1. A new extracorporeal reactor-dialyzer for enzyme therapy using immobilized L-asparaginase.
Jackson JA; Halvorson HR; Furlong JW; Lucast KD; Shore JD
J Pharmacol Exp Ther; 1979 May; 209(2):271-4. PubMed ID: 439002
[TBL] [Abstract][Full Text] [Related]
2. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
Edman P; Nylén U; Sjöholm I
J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269
[TBL] [Abstract][Full Text] [Related]
3. Perfusion trials with a collagen-immobilized enzyme in an extracorporeal reactor: activity, stability, and biocompatibility.
Olanoff LS; Venkatasubramanian K; Bernath FR; Joyeuse R
J Biomed Mater Res; 1977 Jan; 11(1):125-36. PubMed ID: 845182
[TBL] [Abstract][Full Text] [Related]
4. Reduction of canine serum asparagine levels by L -asparaginase immobilized on collagen: a potential form of cancer chemotherapy.
Olanoff LS; Bernath FR; Venkatasubramanian K; Joyeuse R
Trans Am Soc Artif Intern Organs; 1975; 21():156-64. PubMed ID: 807012
[TBL] [Abstract][Full Text] [Related]
5. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
Zhou J; Jin H; Li Y; Jiang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
[TBL] [Abstract][Full Text] [Related]
6. An extracorporeal chemical reactor.
Martel L; Rotteveel J; Snider MT; Galletti PM
Trans Am Soc Artif Intern Organs; 1970; 16():504-7. PubMed ID: 5454205
[No Abstract] [Full Text] [Related]
7. Hollow fiber immobilized L-asparaginase: in vivo and in vitro immunological studies.
Callegaro L; Assone F; Cecconato E; Malinverni A; Pasteris V; Rossi V
Int J Artif Organs; 1983 Mar; 6(2):91-6. PubMed ID: 6840898
[TBL] [Abstract][Full Text] [Related]
8. A Dacron wool packed-bed extracorporeal reactor: a kinetic study of immobilized Escherichia coli II L-asparaginase.
KO RY; Hersh LS
J Biomed Mater Res; 1976 Mar; 10(2):249-58. PubMed ID: 3508
[TBL] [Abstract][Full Text] [Related]
9. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
[TBL] [Abstract][Full Text] [Related]
10. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
[TBL] [Abstract][Full Text] [Related]
11. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
12. [X-ray microanalysis of the activity of immobilized L-asparaginase].
Ding L; Yao ZH
Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Sep; 24(9):1136-9. PubMed ID: 15762544
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor.
Asselin BL; Lorenson MY; Whitin JC; Coppola DJ; Kende AS; Blakley RL; Cohen HJ
Cancer Res; 1991 Dec; 51(24):6568-73. PubMed ID: 1742729
[TBL] [Abstract][Full Text] [Related]
14. Applications of bioreactors in medicine.
Callegaro L; Denti E
Int J Artif Organs; 1983 Jul; 6 Suppl 1():107-10. PubMed ID: 6358050
[TBL] [Abstract][Full Text] [Related]
15. Transport of L-asparagine in Tetrahymena pyriformis ecto-L-asparaginase is not related to L-asparagine-protein transport system.
Tsavdaridis IK; Triantafillou DJ; Kyriakidis DA
Biochem Int; 1991 May; 24(2):281-90. PubMed ID: 1930247
[TBL] [Abstract][Full Text] [Related]
16. [High molecular weight L-asparaginase derivatives based on a water-soluble carboxymethyl cellulose: biological properties].
Karsakevich AS; Kinstler OB; Dauvarte AZh; Vina IA
Vopr Med Khim; 1988; 34(3):107-10. PubMed ID: 3420797
[TBL] [Abstract][Full Text] [Related]
17. Immobilized carboxypeptidase G1 in methotrexate removal.
Bertino JR; Condos S; Horvath C; Kalghatgi K; Pedersen H
Cancer Res; 1978 Jul; 38(7):1936-41. PubMed ID: 657131
[TBL] [Abstract][Full Text] [Related]
18. Preparation of immobilized L-phenylalanine ammonia-lyase in tubular form for depletion of L-phenylalanine.
Pedersen H; Horvath C; Ambrus CM
Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):559-69. PubMed ID: 674832
[TBL] [Abstract][Full Text] [Related]
19. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
20. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
